OSCR
Oscar Health·NYSE
--
--(--)
--
--(--)
4.84 / 10
Netural
Fund flow evaluation is positive at 7.78/10, suggesting robust money inflows despite adverse overall and block trends. Analyst consensus is neutral, with two recent 'Neutral' ratings from UBS and Barclays. The combination of positive fund flow and neutral analyst views provides some support, but the lack of bullish analyst conviction limits upside momentum.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-05
InstitutionBarclays
Times predicted4
Historical Win Rate50.0%
What is the analyst consensus for OSCR?
- OSCR holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.84/10 (Netural).
